BCL2 and cancer: Moreover, previous data showed that BV acts as an anti-cancer agent through apoptosis, necrosis, and lysis induction of tumor cells via the activation of several signaling pathways involving a Bcl-2 protein, caspase 3, in synovial fibroblasts [32].